A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort
Abstract Alzheimer’s Disease (AD) is the most common form of dementia, characterised by extracellular amyloid deposition as plaques and intracellular neurofibrillary tangles of tau protein. As no current clinical test can diagnose individuals at risk of developing AD, the aim of this project is to e...
Guardado en:
Autores principales: | Steve Pedrini, Veer B. Gupta, Eugene Hone, James Doecke, Sid O’Bryant, Ian James, Ashley I. Bush, Christopher C. Rowe, Victor L. Villemagne, David Ames, Colin L. Masters, Ralph N. Martins, AIBL Research Group |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/28c8e933dd1349c98d3838986758d187 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MR-less surface-based amyloid assessment based on 11C PiB PET.
por: Luping Zhou, et al.
Publicado: (2014) -
Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
por: James R. Hall, et al.
Publicado: (2021) -
Novel STAT binding elements mediate IL-6 regulation of MMP-1 and MMP-3
por: Samuel J. Cutler, et al.
Publicado: (2017) -
A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.
por: Leigh A Johnson, et al.
Publicado: (2013) -
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
por: Samantha L. Gardener, et al.
Publicado: (2021)